Searched for
LAL PATHLABS
Dr. Lal PathLabs shares turn ex-bonus tomorrow for 1:1 issue, last day to buy for eligibilityAs per the corporate filings, the company will issue one fully paid-up bonus equity share of face value Rs 10 for every one existing fully ...18 Dec, 2025, 07.46 AM IST- Buy Dr. Lal Pathlabs, target price Rs 3181: BNP Paribas SecuritiesDr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 19103.91 Crore) operating in Hospital...05 Apr, 2024, 10.23 AM IST
- Dr Lal PathLabs Q1 FY24 net profit rises 44% to Rs 84 croreDr Lal PathLabs' Q1FY24 net profit surged 44% YoY to INR84 crore due to the rise in non-Covid testing and higher realisations, while non-Co...27 Jul, 2023, 07.18 PM IST
- Dr Lal PathLabs Q3 Results: Net profit drops 8% to Rs 54 croreDr Lal PathLabs said its emphasis is on improving the market penetration through franchisee model, and leveraging the digital infrastructur...02 Feb, 2023, 08.21 PM IST
- Dr Lal PathLabs to use drones for transporting blood samplesThe use of drones would expand Dr Lal PathLabs services of high-quality and advanced diagnostics to underserved and inaccessible locations,...05 Apr, 2022, 04.41 PM IST
- Dr Lal PathLabs Q2 results: Net profit up 11% at Rs 96 croreOperating revenue of the company increased by 15.4 per cent in Q2 FY22 to Rs 498.4 crore as compared with Rs 431.9 crore in Q2 FY21, Dr Lal...27 Oct, 2021, 12.13 AM IST
- Dr Lal PathLabs Q4 results: Net profit jumps over 2.5 times to Rs 85 crIts consolidated revenue from operations stood at Rs 431 crore for the quarter under consideration. It was Rs 301.7 crore for the same peri...21 May, 2021, 08.08 PM IST
- Dr Lal PathLabs Q2 results: Net profit up 7.5% to Rs 87 crRevenue from operations stood at Rs 431.9 crore for the quarter under consideration. It was Rs 365.6 crore for the same period a year ago, ...06 Nov, 2020, 05.05 PM IST
- Dr Lal PathLabs Q1 results: Net profit declines 52% to Rs 28.4 croreThe company had posted a net profit of Rs 59.1 crore for the corresponding period of the previous fiscal, Dr Lal PathLabs said in a filing ...31 Jul, 2020, 04.24 PM IST
- Dr Lal PathLabs Q4 results: Net profit declines 31% to Rs 32.6 croreThe company had posted a net profit of Rs 47.4 crore for the corresponding period of previous fiscal.18 May, 2020, 05.38 PM IST
- Buy Dr Lal PathLabs, target price Rs 1,860: CLSAThe brokerage has lowered volume assumptions by 2-5 per cent over FY20-FY22.27 Mar, 2020, 08.54 AM IST
- Dr Lal PathLabs to acquire 70 pc stake in Amins Pathology Referral LaboratoryThe acquisition will further strengthen the company's network in Gujarat and adjoining areas01 Oct, 2019, 07.08 PM IST
- CLSA maintains 'buy' on Dr Lal PathLabsDr Lal PathLabs' volume growth in the past two quarters has been encouraging.09 Feb, 2018, 03.24 PM IST
- Nomura upgrades Dr Lal PathLabs to 'buy' from 'neutral'The brokerage said growth in recent times in Dr Lal PathLabs has been hit by demonetisation but it remains constructive on long term growth...21 Mar, 2017, 02.14 PM IST
- Dr Lal PathLabs Q3 profit more than doubles to Rs 61 croreDr Lal PathLabs today reported over two-fold jump in consolidated net profit at Rs 60.82 crore for the third quarter ended December 31, 201...13 Feb, 2016, 07.22 PM IST
- TA Associates buys minority stake in Lal PathLabsTA Associates made a minority investment in Dr Lal PathLabs by purchasing half of Sequoia Capital’s stake in the company for an undisclosed...27 Aug, 2010, 01.44 AM IST
- Sequoia to sell around 15% in PathLabsSequoia Capital has put a part of its 30% stake in one of the country’s largest diagnostics and pathology services chain, Dr Lal PathLabs, ...24 May, 2010, 12.25 AM IST
Load More
